AAA
OPTR

Alpine Associates Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Alpine Associates Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,213,127
Closed -$27.9M – 100
2013
Q3 		$27.9M Buy
+2,213,127
New +$29.3M 1.12% 29

Alpine Associates Advisors's OPTR Position: Q4 2013 in Review

Alpine Associates Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,213,127 shares — an estimated $27.9M sold.

Alpine Associates Advisors first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $27.9M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Alpine Associates Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Alpine Associates Advisors sold 2,213,127 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $27.9M.
  • Alpine Associates Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Alpine Associates Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $27.9M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Alpine Associates Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.